AVBP
Price
$19.38
Change
-$0.57 (-2.86%)
Updated
Oct 7, 12:59 PM (EDT)
Capitalization
809.35M
37 days until earnings call
MAIA
Price
$1.89
Change
+$0.16 (+9.25%)
Updated
Oct 7, 03:26 PM (EDT)
Capitalization
57.08M
28 days until earnings call
Interact to see
Advertisement

AVBP vs MAIA

Header iconAVBP vs MAIA Comparison
Open Charts AVBP vs MAIABanner chart's image
ArriVent BioPharma
Price$19.38
Change-$0.57 (-2.86%)
Volume$100
Capitalization809.35M
MAIA Biotechnology
Price$1.89
Change+$0.16 (+9.25%)
Volume$405
Capitalization57.08M
AVBP vs MAIA Comparison Chart in %
AVBP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MAIA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AVBP vs. MAIA commentary
Oct 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AVBP is a StrongBuy and MAIA is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 07, 2025
Stock price -- (AVBP: $19.95 vs. MAIA: $1.73)
Brand notoriety: AVBP and MAIA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AVBP: 81% vs. MAIA: 79%
Market capitalization -- AVBP: $809.35M vs. MAIA: $57.08M
AVBP [@Biotechnology] is valued at $809.35M. MAIA’s [@Biotechnology] market capitalization is $57.08M. The market cap for tickers in the [@Biotechnology] industry ranges from $103.3B to $0. The average market capitalization across the [@Biotechnology] industry is $2.05B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AVBP’s FA Score shows that 1 FA rating(s) are green whileMAIA’s FA Score has 0 green FA rating(s).

  • AVBP’s FA Score: 1 green, 4 red.
  • MAIA’s FA Score: 0 green, 5 red.
According to our system of comparison, AVBP is a better buy in the long-term than MAIA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AVBP’s TA Score shows that 4 TA indicator(s) are bullish while MAIA’s TA Score has 6 bullish TA indicator(s).

  • AVBP’s TA Score: 4 bullish, 4 bearish.
  • MAIA’s TA Score: 6 bullish, 3 bearish.
According to our system of comparison, MAIA is a better buy in the short-term than AVBP.

Price Growth

AVBP (@Biotechnology) experienced а +9.86% price change this week, while MAIA (@Biotechnology) price change was +8.13% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.94%. For the same industry, the average monthly price growth was +16.24%, and the average quarterly price growth was +90.12%.

Reported Earning Dates

AVBP is expected to report earnings on Nov 13, 2025.

MAIA is expected to report earnings on Nov 04, 2025.

Industries' Descriptions

@Biotechnology (+7.94% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AVBP($809M) has a higher market cap than MAIA($57.1M). MAIA YTD gains are higher at: -12.626 vs. AVBP (-25.113). MAIA has higher annual earnings (EBITDA): -26.12M vs. AVBP (-148.33M). AVBP has more cash in the bank: 236M vs. MAIA (10.1M). AVBP (0) and MAIA (0) have equivalent revenues.
AVBPMAIAAVBP / MAIA
Capitalization809M57.1M1,417%
EBITDA-148.33M-26.12M568%
Gain YTD-25.113-12.626199%
P/E RatioN/AN/A-
Revenue00-
Total Cash236M10.1M2,337%
Total Debt98KN/A-
TECHNICAL ANALYSIS
Technical Analysis
AVBPMAIA
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
82%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
74%
Bullish Trend 2 days ago
90%
MACD
ODDS (%)
Bullish Trend 2 days ago
69%
Bullish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
89%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
86%
Advances
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 6 days ago
88%
Declines
ODDS (%)
Bearish Trend 13 days ago
90%
Bearish Trend 8 days ago
89%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
82%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
85%
Bullish Trend 2 days ago
84%
View a ticker or compare two or three
Interact to see
Advertisement
AVBP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MAIA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PENNX9.760.02
+0.21%
Royce Small-Cap Fund Invmt
UUPIX88.84N/A
N/A
ProFunds UltraEmerging Markets Inv
PINIX16.49N/A
N/A
Principal International Equity Inst
ELDFX23.22N/A
N/A
Elfun Diversified
CCSMX24.84N/A
N/A
Conestoga SMid Cap Investors

AVBP and

Correlation & Price change

A.I.dvisor indicates that over the last year, AVBP has been loosely correlated with SYRE. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if AVBP jumps, then SYRE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AVBP
1D Price
Change %
AVBP100%
+0.55%
SYRE - AVBP
52%
Loosely correlated
+4.91%
ELVN - AVBP
49%
Loosely correlated
+3.52%
DNLI - AVBP
48%
Loosely correlated
-1.30%
RVMD - AVBP
45%
Loosely correlated
-0.28%
OCUL - AVBP
45%
Loosely correlated
-3.86%
More